Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
crossref(2024)
Abstract
Ongoing clinical trial of phosphorylation-associated small molecule drugs and anti-PD-1/PD-L1 combination
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined